Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biostage, Inc. stock logo
BSTG
Biostage
$4.45
$4.45
$4.45
$4.45
$61.78M-1.021,847 shsN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.55
-3.5%
$0.47
$0.37
$1.51
$2.71M0.45368,027 shs66,628 shs
LLIT
Lianluo Smart
$0.83
+5.1%
$9.91
$2.76
$17.14
$1.84M0.161.04 million shs226,380 shs
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
$0.17
-5.6%
$4.22
$0.66
$10.77
$1.70M-1.237.68 million shs317,860 shs
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biostage, Inc. stock logo
BSTG
Biostage
0.00%0.00%0.00%0.00%-25.83%
Dynatronics Co. stock logo
DYNT
Dynatronics
-2.44%+3.43%+29.54%+12.60%-60.32%
LLIT
Lianluo Smart
-2.07%+7.82%-14.55%-3.53%-22.92%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
+5.89%+4.28%-2.20%-13.55%-92.12%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
0.8203 of 5 stars
3.03.00.00.00.60.00.6
LLIT
Lianluo Smart
N/AN/AN/AN/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
2.00
Hold$3.80584.81% Upside
LLIT
Lianluo Smart
N/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/A($0.26) per shareN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
$40.61M0.07N/AN/A$2.19 per share0.25
LLIT
Lianluo Smart
$380K4.84N/AN/A($0.59) per share-1.41
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
$1.59M1.07N/AN/A$0.60 per share0.28

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biostage, Inc. stock logo
BSTG
Biostage
-$6.07M-$0.58N/AN/AN/AN/A-174.43%N/A
Dynatronics Co. stock logo
DYNT
Dynatronics
-$4.97M-$1.38N/AN/A-14.13%-54.88%-16.14%5/9/2024 (Estimated)
LLIT
Lianluo Smart
-$4.45MN/A0.00N/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
-$12.33MN/AN/AN/A-776.76%-161.38%-83.58%N/A

Latest DYNT, OBLN, LLIT, and BSTG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/7/2024Q2 2024
Dynatronics Co. stock logo
DYNT
Dynatronics
N/A-$0.27-$0.27-$0.27N/A$8.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biostage, Inc. stock logo
BSTG
Biostage
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
LLIT
Lianluo Smart
N/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biostage, Inc. stock logo
BSTG
Biostage
N/A
2.73
2.73
Dynatronics Co. stock logo
DYNT
Dynatronics
0.21
1.41
0.67
LLIT
Lianluo Smart
N/A
2.42
2.17
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/A
1.86
1.86

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Biostage, Inc. stock logo
BSTG
Biostage
N/A
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
LLIT
Lianluo Smart
28.75%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
18.64%

Insider Ownership

CompanyInsider Ownership
Biostage, Inc. stock logo
BSTG
Biostage
15.30%
Dynatronics Co. stock logo
DYNT
Dynatronics
9.10%
LLIT
Lianluo Smart
22.90%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
8.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Biostage, Inc. stock logo
BSTG
Biostage
713.88 million11.76 millionNot Optionable
Dynatronics Co. stock logo
DYNT
Dynatronics
1544.88 million4.44 millionNot Optionable
LLIT
Lianluo Smart
62.21 millionN/ANot Optionable
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
210.02 millionN/ANot Optionable

DYNT, OBLN, LLIT, and BSTG Headlines

SourceHeadline
Obalon Therapeutics, Inc.Obalon Therapeutics, Inc.
thestreet.com - February 25 at 12:23 PM
Spero Therapeutics Inc.Spero Therapeutics Inc.
wsj.com - February 6 at 3:31 PM
Intragastric Balloon Market Growth and Forecast till 2031Intragastric Balloon Market Growth and Forecast till 2031
marketwatch.com - March 28 at 11:39 PM
Intragastric Balloons Market to Grow with a Significant CAGR During the forecast period 2022-2028| Exclusive Report Spread Across 149 PagesIntragastric Balloons Market to Grow with a Significant CAGR During the forecast period 2022-2028| Exclusive Report Spread Across 149 Pages
marketwatch.com - August 17 at 9:10 PM
Renovare Environmental Inc (RENO)Renovare Environmental Inc (RENO)
investing.com - January 5 at 8:30 AM
Understanding Atara Biotherapeuticss Unusual Options ActivityUnderstanding Atara Biotherapeutics's Unusual Options Activity
benzinga.com - August 10 at 11:04 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Biostage logo

Biostage

OTCMKTS:BSTG
Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.
Dynatronics logo

Dynatronics

NASDAQ:DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Lianluo Smart

NASDAQ:LLIT
Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.
Obalon Therapeutics logo

Obalon Therapeutics

NASDAQ:OBLN
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.